β-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-ĸB signal pathways.

[1]  T. Henry,et al.  Transcriptional Regulation of Inflammasomes , 2020, International journal of molecular sciences.

[2]  D. A. Al Farraj,et al.  Synthesis, Cytotoxic Analysis, and Molecular Docking Studies of Tetrazole Derivatives via N-Mannich Base Condensation as Potential Antimicrobials , 2020, Drug design, development and therapy.

[3]  J. Guh,et al.  Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling , 2020, Frontiers in Oncology.

[4]  J. Edwards,et al.  Determining the prognostic significance of IKKα in prostate cancer , 2020, The Prostate.

[5]  Guang-xin Miao,et al.  Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats. , 2020, Life sciences.

[6]  B. Ma,et al.  β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  S. Kumari,et al.  Androgen receptor co-regulation in prostate cancer , 2019, Asian journal of urology.

[8]  H. G. van der Poel,et al.  EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). , 2019, European urology.

[9]  F. Heidel,et al.  Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation , 2019, Cells.

[10]  Yanru Deng,et al.  Evaluation of Anti-Inflammatory Activities of a Triterpene β-Elemonic Acid in Frankincense In Vivo and In Vitro , 2019, Molecules.

[11]  K. Yoon,et al.  Afrocyclamin A, a triterpene saponin, induces apoptosis and autophagic cell death via the PI3K/Akt/mTOR pathway in human prostate cancer cells. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  K. Kalland,et al.  Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain , 2018, Pharmacology research & perspectives.

[13]  S. Sikka,et al.  Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer , 2018, Cancers.

[14]  Yang Sun,et al.  Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3 , 2018, Journal of Experimental & Clinical Cancer Research.

[15]  Qi Zhang,et al.  Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF‐&kgr;B signal pathway , 2018, Toxicology and applied pharmacology.

[16]  V. Adhami,et al.  Nummularic acid, a triterpenoid, from the medicinal plant Fraxinus xanthoxyloides, induces energy crisis to suppress growth of prostate cancer cells , 2018, Molecular carcinogenesis.

[17]  Xin He,et al.  Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives. , 2018, Current drug metabolism.

[18]  Jason P. Estes,et al.  Cardiovascular and Metabolic Toxicity of Abiraterone in Castration-resistant Prostate Cancer: Post-marketing Experience. , 2018, Clinical genitourinary cancer.

[19]  H. Bang,et al.  Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.

[20]  Yan Zhang,et al.  Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). , 2018, Journal of medicinal chemistry.

[21]  A. Chinnaiyan,et al.  Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC) , 2018, Clinical Cancer Research.

[22]  M. Kortylewski,et al.  Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC) , 2018, Cancer.

[23]  B. Ma,et al.  Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response , 2017, Acta Pharmacologica Sinica.

[24]  F. Fu,et al.  Ginsenoside Rg1 attenuates adjuvant-induced arthritis in rats via modulation of PPAR-γ/NF-κB signal pathway , 2017, Oncotarget.

[25]  Leigh H. Simmons,et al.  Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection. , 2017, The Medical clinics of North America.

[26]  Q. Ng,et al.  Outcomes of Dose-Attenuated Docetaxel in Asian Patients with Castrate-Resistant Prostate Cancer. , 2017, Annals of the Academy of Medicine, Singapore.

[27]  Ming Lei,et al.  Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells , 2017, Theranostics.

[28]  P. Nelson,et al.  Expression of STAT3 in Prostate Cancer Metastases. , 2017, European urology.

[29]  S. Serni,et al.  Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis , 2015, Prostate Cancer and Prostatic Diseases.

[30]  A. Sciarra,et al.  Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review , 2016, Journal of Inflammation.

[31]  Shu-min Liu,et al.  Therapeutic Effect of Total Saponins from Dioscorea nipponica Makino on Gouty Arthritis Based on the NF-κB Signal Pathway: An In vitro Study , 2016, Pharmacognosy magazine.

[32]  Haluk Resat,et al.  Constitutive activation of STAT3 in breast cancer cells: A review , 2016, International journal of cancer.

[33]  B. Goh,et al.  Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model. , 2016, Antioxidants & redox signaling.

[34]  R. Laing,et al.  Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial , 2016, The Lancet.

[35]  R. León,et al.  Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. , 2015, Biochemical pharmacology.

[36]  Qi Zhang,et al.  Triptolide disrupts fatty acids and peroxisome proliferator-activated receptor (PPAR) levels in male mice testes followed by testicular injury: A GC-MS based metabolomics study. , 2015, Toxicology.

[37]  C. Perez-stable,et al.  Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage , 2015, Oncoscience.

[38]  C. Evans,et al.  Mechanisms of resistance in castration-resistant prostate cancer (CRPC) , 2015, Translational andrology and urology.

[39]  R. Montironi,et al.  Role of STAT3 pathway in genitourinary tumors , 2015, Future science OA.

[40]  A. D. Van den Abbeele,et al.  A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. , 2015, Clinical genitourinary cancer.

[41]  R. Matusik,et al.  Inhibition of NF-kappa B signaling restores responsiveness of castrate resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor variants expression , 2014, Oncogene.

[42]  A. Zoubeidi,et al.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer , 2014, Cancers.

[43]  Yezi Zhu,et al.  Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells , 2014, The Prostate.

[44]  D. Mukherji,et al.  Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics , 2014, Cancer and Metastasis Reviews.

[45]  B. Mellado,et al.  Nuclear factor‐kappa B and interleukin‐6 related docetaxel resistance in castration‐resistant prostate cancer , 2013, The Prostate.

[46]  Yihui Fan,et al.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer , 2013, Protein & Cell.

[47]  Qiuyang Zhang,et al.  LNCaP prostate cancer cells with autocrine interleukin‐6 expression are resistant to IL‐6‐induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling , 2012, The Prostate.

[48]  M. Karin,et al.  NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.

[49]  M. Karin,et al.  NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.

[50]  J. Machiels,et al.  Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial , 2010, The Lancet.

[51]  C. Zheng,et al.  Corosolic acid-induced acute kidney injury and lactic acidosis in a patient with impaired kidney function. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  Deming Zhao,et al.  Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro , 2008, Journal of Neuroimmunology.

[53]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  W. Farrar,et al.  Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. , 2000, Cancer research.